Document Detail

Ambrisentan for Pulmonary Arterial Hypertension Due to Congenital Heart Disease.
MedLine Citation:
PMID:  21371683     Owner:  NLM     Status:  Publisher    
Eisenmenger syndrome (ES) is a known complication of congenital heart disease associated with unrepaired systemic to pulmonary shunts. Evidence for use of targeted pulmonary arterial hypertension therapy in ES is limited. The early experience using ambrisentan was evaluated in a cohort of consecutive patients with ES who initiated ambrisentan at Columbia University's Pulmonary Hypertension Center from January 1, 2007, to August 1, 2008. Effects of ambrisentan on rest and exercise systemic arterial oxygen saturation (S(a)O(2)), exercise capacity, functional status, hemoglobin levels, and hemodynamics were evaluated and compared using paired Student's t tests. Seventeen patients were evaluated at short-term (mean 163 ± 57 days) and longer term (mean 2.5 ± 0.5 years) follow-up. At short-term follow-up, there was an improvement in exercise capacity (6-minute walking distance 389 ± 74 vs 417 ± 77 m, p = 0.03, n = 11) and maintenance of rest S(a)O(2) (89 ± 7% vs 89% ± 6%, p = 0.75, n = 15), exercise S(a)O(2) (75 ± 15% vs 77% ± 15%, p = 0.33, n = 11), functional class (improvement in 2 patients, no change in 13), and hemoglobin (16.5 ± 2.8 vs 15.8 ± 1.8 g/dl, p = 0.11, n = 14). At longer term follow-up compared to baseline and short-term follow-up, there was stability of exercise capacity, S(a)O(2), functional class, and hemoglobin. In conclusion, in this single-center cohort of patients with ES, ambrisentan was safe and was associated with increasing exercise capacity at short-term follow-up, with patients maintaining S(a)O(2), functional class, and hemoglobin, and with no significant evidence of clinical deterioration at longer term follow-up. Additional studies are required to further assess the efficacy of ambrisentan in patients with ES.
Warren A Zuckerman; Derek Leaderer; Cherise A Rowan; Johnell D Mituniewicz; Erika Berman Rosenzweig
Related Documents :
737243 - Isozyme profiles of lactic dehydrogenase and creatine phosphokinase in neonatal mouse h...
6631303 - Oestrogen levels in the blood, not in the uterus, determine uterine eosinophilia and oe...
24848763 - Impact of acute whole-body cold exposure with concurrent isometric handgrip exercise on...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-1
Journal Detail:
Title:  The American journal of cardiology     Volume:  -     ISSN:  1879-1913     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Columbia University Medical Center, New York, New York.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Relation Between Migraine and Size of Echocardiographic Intrapulmonary Right-to-Left Shunt.
Next Document:  Diagnostic and Prognostic Value of Electrophysiologic Study in Patients With Nondocumented Palpitati...